Magnolia Capital Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$315K Buy
11,868
+3
+0% +$80 0.08% 197
2025
Q1
$287K Buy
11,865
+810
+7% +$19.6K 0.08% 194
2024
Q4
$445K Buy
+11,055
New +$445K 0.12% 164